Clinical Trial Update: Effect of Oral Phloroglucin (Flospan®) as Premedication of Non-sedative Diagnostic Esophagogastroduodenoscopy [Phase 3]

View source ↗

Summary

Phase 3 trial assessing oral Phloroglucin (Flospan) as premedication for non-sedative diagnostic esophagogastroduodenoscopy; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Peristalsis Disturbance
• Non-sedative Endoscopy-related Indications

Drugs mentioned

• Flospan

Snippet

Sponsor: Keimyung University Dongsan Medical Center | Conditions: Anti-spasmodics, Gastric Peristalsis | Phase 3 | Status: COMPLETED